Testosterone cream
Testosterone cream is compounded off-label for low sexual desire in postmenopausal women. No FDA-approved testosterone product for women exists in the US.
How it works
Testosterone cream for women is prepared by compounding pharmacies in concentrations much lower than male testosterone products. It is typically applied to the inner arm, thigh, or labia majora (for genital application, which may have benefits for sexual response specifically). Because it is compounded, potency and purity are not regulated by the FDA — batch variability can affect symptom consistency, making monitoring via blood levels essential. The Global Consensus Statement (2019) identifies testosterone as evidence-based specifically for hypoactive sexual desire disorder (HSDD) in postmenopausal women.
Absorption from topical cream is affected by the application site, skin condition, and the specific formulation. Supraphysiologic testosterone levels — which can occur if the dose or concentration is too high — increase the risk of androgenic side effects (acne, oily skin, hair changes) and should be avoided. Blood level monitoring (total and free testosterone) is recommended to keep levels within the normal premenopausal female range.
How to track Testosterone cream
- Sexual desire and satisfaction — the primary evidence-based indication; rate consistently before and throughout treatment.
- Application site and timing consistency — cream absorption varies by site; tracking application details helps explain any variability in response.
- Blood testosterone level test dates and results — essential monitoring to stay within the premenopausal female reference range.
- Androgenic side effects: acne, oily skin, body or facial hair changes — dose-related and should be logged promptly.
- Energy and wellbeing as secondary response measures — commonly reported but less well-evidenced than sexual desire.
- Rate sexual desire on a consistent scale from before you start — even a simple 1–10 scale applied consistently gives you and your physician measurable data.
- Log the application site and amount applied for each dose — absorption from cream varies significantly between sites (arm vs. inner thigh vs. genital), and consistency of site is important for consistent levels.
- Track blood test dates and results in the same log as symptom data — they are part of the same monitoring picture.
- Log androgenic side effects at first appearance with date and severity — acne or hair changes appearing shortly after a dose increase are a clear signal.
- Note the compounding pharmacy, concentration, and any product changes — batch-to-batch variability from compounding can cause unexplained symptom fluctuation.
Questions to ask your physician
- My sexual desire rating before starting testosterone cream was [X]. At [N] weeks, my current rating is [Y]. Is that response consistent with the evidence for topical testosterone in HSDD?
- My most recent testosterone blood level was [X] on [date]. Is that within the target range for premenopausal female levels?
- I've been logging androgenic side effects (acne, hair changes) at [severity] since [date]. Does that pattern suggest dose or concentration adjustment?
- I'm using a compounded product from [pharmacy] at [concentration]. Has my physician noted any quality concerns about this compounding source?